MedTrace Logo

Biomarkers in Patients With Acute Myeloid Leukemia

NCT01138319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2015-05-06

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA analysis

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Jason H. Bielas, PhD · Fred Hutchinson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01138319 on ClinicalTrials.gov